Hui Lin
Impact in
-
- Chemotherapy-induced cardiotoxicity and mitigation
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Function and Risk Factors
- Nephrology top 5%
Papers in
-
- Atrial Fibrillation Management and Outcomes 8
- Cardiac Arrhythmias and Treatments 5
- Chemotherapy-induced cardiotoxicity and mitigation 5
- Cardiac pacing and defibrillation studies 4
-
- Inflammasome and immune disorders 3
- Co-authors
- Liping Meng (19 shared papers)Tingjuan Ni (8 shared papers)Zhenzhu Sun (5 shared papers)Hangyuan Guo (16 shared papers)Xingxiao Huang (4 shared papers)Jufang Chi (11 shared papers)Jie Zhang (4 shared papers)Hangyuan Guo (9 shared papers)
- Journals
- Scientific Reports (3 papers)Frontiers in Pharmacology (3 papers)EP Europace (2 papers)Journal of Cellular and Molecular Medicine (2 papers)Antioxidants and Redox Signaling (2 papers)
- Partner nations
- ChinaEstoniaUnited States
In The Last Decade
Hui Lin
66 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 97
- Cardiology and Cardiovascular Medicine 401
- Nephrology 109
- Geriatrics and Gerontology 37
- Cancer Research 161
- Clinical Biochemistry 66
Countries citing papers authored by Hui Lin
This map shows the geographic impact of Hui Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Lin more than expected).
Fields of papers citing papers by Hui Lin
This network shows the impact of papers produced by Hui Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Lin. The network helps show where Hui Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 137 | |
| 2 | 2020 | 128 | |
| 3 | 2020 | 113 | |
| 4 | 2019 | 100 | |
| 5 | 2021 | 64 | |
| 6 | 2020 | 49 | |
| 7 | 2019 | 48 | |
| 8 | 2017 | 47 | |
| 9 | 2006 | 46 | |
| 10 | 2013 | 38 | |
| 11 | 2005 | 34 | |
| 12 | 2018 | 31 | |
| 13 | 2017 | 31 | |
| 14 | 2011 | 30 | |
| 15 | 2023 | 29 | |
| 16 | 2017 | 27 | |
| 17 | 2006 | 27 | |
| 18 | 2014 | 27 | |
| 19 | 2021 | 25 | |
| 20 | 2012 | 23 |
About Hui Lin
Hui Lin is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Surgery, Epidemiology and Cancer Research, having authored 72 papers that have together received 1.4k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (8 papers), Cardiac Arrhythmias and Treatments (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (5 papers), Cardiac pacing and defibrillation studies (4 papers), Chronic Kidney Disease and Diabetes (3 papers), Inflammasome and immune disorders (3 papers), Autophagy in Disease and Therapy (3 papers) and Folate and B Vitamins Research (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (401 citations), Nephrology (109 citations), Geriatrics and Gerontology (37 citations), Cancer Research (161 citations) and Clinical Biochemistry (66 citations). Hui Lin has collaborated with scholars based in China, Estonia and United States. Frequent co-authors include Liping Meng, Tingjuan Ni, Zhenzhu Sun, Hangyuan Guo, Xingxiao Huang, Jufang Chi, Jie Zhang, Hangyuan Guo, Fang Peng and Feidan Gao. Their work appears in journals such as Scientific Reports, Frontiers in Pharmacology, EP Europace, Journal of Cellular and Molecular Medicine and Antioxidants and Redox Signaling.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.